Literature DB >> 22815207

Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis.

Landon N Olp1, Danielle M Shea, Maxine K White, Clement Gondwe, Chipepo Kankasa, Charles Wood.   

Abstract

Sub-Saharan Africa is endemic for Kaposi's sarcoma-associated herpesvirus (KSHV) and there is a high rate of early childhood infection; however, the transmission sources are not well characterized. We examined household members as potential KSHV transmission sources to young children in the KSHV-endemic country of Zambia. To this end, we enrolled and followed Zambian households with at least one KSHV-seropositive child and collected longitudinal buccal swab samples. KSHV burden was evaluated and K1 sequences from the children were determined and analyzed for differences to K1 sequences from household members. The K1 sequences were also analyzed for evolution over time. We generated K1 sequences from 31 individuals across 16 households. Nine households contained multiple KSHV-positive members, including at least one child. In six out of the nine households, the child had 100% sequence identity to all household members. However, in two households the child and mother had distinct K1 sequences. In the remaining household, the children were the only KSHV-infected individuals. Furthermore, we report that 1 out of 18 individuals had K1 sequence variation within the timespan analyzed. In our study, we provide evidence that (i) early childhood KSHV transmission occurs from both within and outside the household, (ii) intrahousehold transmission can occur via nonmaternal sources, (iii) viral shedding in the buccal cavity is highly variable and (iv) the dominant K1 sequence within an individual did not rapidly evolve over time. These results are important for developing KSHV intervention strategies.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815207      PMCID: PMC3535687          DOI: 10.1002/ijc.27729

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma.

Authors:  Isabelle C Widmer; Peter Erb; Heini Grob; Peter Itin; Michele Baumann; Aline Stalder; Rainer Weber; Gieri Cathomas
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

Review 3.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).

Authors:  T F Schulz
Journal:  J Gen Virol       Date:  1998-07       Impact factor: 3.891

4.  Vertical transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Mantina; C Kankasa; W Klaskala; B Brayfield; J Campbell; Q Du; G Bhat; F Kasolo; C Mitchell; C Wood
Journal:  Int J Cancer       Date:  2001-12-01       Impact factor: 7.396

Review 5.  Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.

Authors:  Melanie M Brinkmann; Thomas F Schulz
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

6.  Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group.

Authors:  P M Cook; D Whitby; M L Calabro; M Luppi; D N Kakoola; H Hjalgrim; K Ariyoshi; B Ensoli; A J Davison; T F Schulz
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

7.  Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Authors:  P R Gorry; G Bristol; J A Zack; K Ritola; R Swanstrom; C J Birch; J E Bell; N Bannert; K Crawford; H Wang; D Schols; E De Clercq; K Kunstman; S M Wolinsky; D Gabuzda
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.

Authors:  Sam Mbulaiteye; Vickie Marshall; Rachel K Bagni; Cheng-Dian Wang; Georgina Mbisa; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Eric A Engels; Edward Katongole-Mbidde; Robert J Biggar; Denise Whitby
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

9.  Human herpesvirus 8 infection within families in rural Tanzania.

Authors:  Sam M Mbulaiteye; Ruth M Pfeiffer; Denise Whitby; Glen R Brubaker; John Shao; Robert J Biggar
Journal:  J Infect Dis       Date:  2003-06-01       Impact factor: 5.226

Review 10.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.

Authors:  M Dedicoat; R Newton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  14 in total

1.  Whole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.

Authors:  Landon N Olp; Adrien Jeanniard; Clemence Marimo; John T West; Charles Wood
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

2.  Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Authors:  Angela Nalwoga; Marjorie Nakibuule; Vickie Marshall; Wendell Miley; Nazzarena Labo; Stephen Cose; Denise Whitby; Robert Newton
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

3.  Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma.

Authors:  Peter O Oluoch; Cliff I Oduor; Catherine S Forconi; John M Ong'echa; Christian Münz; Dirk P Dittmer; Jeffrey A Bailey; Ann M Moormann
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

4.  Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus.

Authors:  Lisa K Poppe; Chipepo Kankasa; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

5.  Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.

Authors:  Landon N Olp; Veenu Minhas; Clement Gondwe; Chipepo Kankasa; Janet Wojcicki; Charles Mitchell; John T West; Charles Wood
Journal:  J Natl Cancer Inst       Date:  2015-07-16       Impact factor: 13.506

6.  Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices.

Authors:  Kay L Crabtree; Janet M Wojcicki; Veenu Minhas; David R Smith; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-02       Impact factor: 4.254

7.  The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression.

Authors:  Lisa K Poppe; Charles Wood; John T West
Journal:  J Immunol       Date:  2020-09-30       Impact factor: 5.422

8.  Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.

Authors:  Hem C Jha; Jie Lu; Subhash C Verma; Shuvomoy Banerjee; Devan Mehta; Erle S Robertson
Journal:  mBio       Date:  2014-12-16       Impact factor: 7.867

Review 9.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

10.  Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia.

Authors:  Rabecca Tembo; Trevor Kaile; Doris Kafita; Chrispin Chisanga; Annie Kalonda; Ephraim Zulu; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2017-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.